WHO Drug Information Vol. 19, No. 3, 2005
(2005; 72 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuPersonal Perspectives
Ouvrir ce répertoire et afficher son contenuSafety and Efficacy Issues
Ouvrir ce répertoire et afficher son contenuHerbal Medicines
Ouvrir ce répertoire et afficher son contenuRegulatory Action and News
Fermer ce répertoireEssential Medicines
Fermer ce répertoireHighlights of the 14th Model List of Essential Medicines
Afficher le documentMethadone and buprenorphine
Afficher le documentMifepristone with misoprostol
Afficher le documentWHO Model List of Essential Medicines
Ouvrir ce répertoire et afficher son contenuAccess to Medicines
Ouvrir ce répertoire et afficher son contenuThe International Pharmacopoeia
Afficher le documentRecommended International Nonproprietary Names: List 54
 

Highlights of the 14th Model List of Essential Medicines

The WHO Expert Committee on the Selection and Use of Essential Medicines met in Geneva in March 2005. Their task was to evaluate evidence-based material relating to the maintenance and updating of the Model List of Essential Medicines. The Model List presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost effective medicines for priority conditions. Two important items from the draft report (http://www.who.int/medicines/library/general/1-ReportFinal-unedited_010705.pdf) are presented below and the latest revision of the 14th Model List of Essential Medicines can be found on page 224.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 19 janvier 2012